437 related articles for article (PubMed ID: 28013032)
1. Radiation therapy for malignant phyllodes tumor of the breast: An analysis of SEER data.
Kim YJ; Kim K
Breast; 2017 Apr; 32():26-32. PubMed ID: 28013032
[TBL] [Abstract][Full Text] [Related]
2. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program.
Macdonald OK; Lee CM; Tward JD; Chappel CD; Gaffney DK
Cancer; 2006 Nov; 107(9):2127-33. PubMed ID: 16998937
[TBL] [Abstract][Full Text] [Related]
3. The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis.
Zhao W; Tian Q; Zhao A; Wang B; Yang J; Wang L; Zhang L; Dong D; Chen L; Yang J
Breast Cancer; 2021 Jan; 28(1):110-118. PubMed ID: 32748225
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Recurrence of Malignant Phyllodes Tumors of the Breast.
Park HJ; Ryu HS; Kim K; Shin KH; Han W; Noh DY
In Vivo; 2019; 33(1):263-269. PubMed ID: 30587634
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
6. Rethinking on the management strategy of malignant phyllodes tumor of the breast: An analysis based on the SEER database.
Chen C; Huang X; Xu Y; Sun Q
Medicine (Baltimore); 2023 Mar; 102(12):e33326. PubMed ID: 36961178
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant radiation therapy and survival for adenoid cystic carcinoma of the breast.
Sun JY; Wu SG; Chen SY; Li FY; Lin HX; Chen YX; He ZY
Breast; 2017 Feb; 31():214-218. PubMed ID: 27915203
[TBL] [Abstract][Full Text] [Related]
8. Malignant phyllodes tumor of the breast: treatment and prognosis.
Mituś J; Reinfuss M; Mituś JW; Jakubowicz J; Blecharz P; Wysocki WM; Skotnicki P
Breast J; 2014; 20(6):639-44. PubMed ID: 25227987
[TBL] [Abstract][Full Text] [Related]
9. Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast.
Zhang H; Tang S; Biskup E; Zhang Y; Yong L; Chen L; Cai F
Technol Cancer Res Treat; 2022; 21():15330338221121086. PubMed ID: 36000314
[No Abstract] [Full Text] [Related]
10. Effect of radiation therapy on patients with stage T3 or T4 malignant phyllodes tumors: a retrospective observational study based on SEER.
Zhang G; Yang P; Zeng J; Wei C
J Cancer Res Clin Oncol; 2023 Dec; 150(1):2. PubMed ID: 38153521
[TBL] [Abstract][Full Text] [Related]
11. Phyllodes tumor of the breast.
Belkacémi Y; Bousquet G; Marsiglia H; Ray-Coquard I; Magné N; Malard Y; Lacroix M; Gutierrez C; Senkus E; Christie D; Drumea K; Lagneau E; Kadish SP; Scandolaro L; Azria D; Ozsahin M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):492-500. PubMed ID: 17931796
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
[TBL] [Abstract][Full Text] [Related]
13. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
[TBL] [Abstract][Full Text] [Related]
14. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
[No Abstract] [Full Text] [Related]
15. Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.
Hong R; Dai Z; Zhu W; Xu B
PLoS One; 2015; 10(10):e0138908. PubMed ID: 26513258
[TBL] [Abstract][Full Text] [Related]
16. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
17. An analysis of 78 breast sarcoma patients without distant metastases at presentation.
McGowan TS; Cummings BJ; O'Sullivan B; Catton CN; Miller N; Panzarella T
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):383-90. PubMed ID: 10661345
[TBL] [Abstract][Full Text] [Related]
18. Survival benefit with radiation therapy in node-positive breast carcinoma patients.
Voordeckers M; Vinh-Hung V; Lamote J; Bretz A; Storme G
Strahlenther Onkol; 2009 Oct; 185(10):656-62. PubMed ID: 19806330
[TBL] [Abstract][Full Text] [Related]
19. Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
Wang J; Yang SP; Zhou P; Lian CL; Lei J; Hua L; He ZY; Wu SG
Cancer Med; 2021 Mar; 10(5):1634-1643. PubMed ID: 33586323
[TBL] [Abstract][Full Text] [Related]
20. Omitting Adjuvant Radiotherapy for Hormone Receptor‒Positive Early-Stage Breast Cancer in Old Age: A Propensity Score Matched SEER Analysis.
Kim YJ; Shin KH; Kim K
Cancer Res Treat; 2019 Jan; 51(1):326-336. PubMed ID: 29747486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
